Litcius/Paper detail

Hematopoietic Stem Cell Transplantation Activity in China 2020–2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group

Lan‐Ping Xu, Dao‐Pei Lu, Depei Wu, Erlie Jiang, Dai‐Hong Liu, He Huang, Zi-Min Sun, Nai-Nong Li, Qifa Liu, Xi Zhang, Yong-Rong Lai, Yongping Song, Xianmin Song, Sixi Liu, Yicheng Zhang, Chengjuan Luo, Linghui Xia, Ting Niu, Yu Yu, Xiaohui Zhang, Xiaowen Tang, Yi Luo, Xiao‐Jun Huang

2022Transplantation and Cellular Therapy31 citationsDOIOpen Access PDF

Topics & Concepts

PandemicHematopoietic stem cell transplantationCoronavirus disease 2019 (COVID-19)Stem cellTransplantationMedicine2019-20 coronavirus outbreakHaematopoiesisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Hematopoietic cellVirologyImmunologyBiologyInternal medicineDiseaseGeneticsInfectious disease (medical specialty)OutbreakHematopoietic Stem Cell TransplantationMesenchymal stem cell researchCAR-T cell therapy research
Hematopoietic Stem Cell Transplantation Activity in China 2020–2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group | Litcius